Cargando…

Platelet function-guided modification in antiplatelet therapy after acute ischemic stroke is associated with clinical outcomes in patients with aspirin nonresponse

PURPOSE: To investigate the association of clinical outcomes with platelet function-guided modification in antiplatelet therapy in patients with ischemic stroke. RESULTS: Among 812 patients, 223 patients had aspirin nonresponse, 204 patients was modified in antiplatelet therapy after platelet functi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yi, Xingyang, Lin, Jing, Wang, Chun, Huang, Ruyue, Han, Zhao, Li, Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739731/ https://www.ncbi.nlm.nih.gov/pubmed/29290946 http://dx.doi.org/10.18632/oncotarget.22293

Ejemplares similares

Low-Molecular-Weight Heparin or Dual Antiplatelet Therapy Is More Effective Than Aspirin Alone in Preventing Early Neurological Deterioration and Improving the 6-Month Outcome in Ischemic Stroke Patients
por: Yi, Xingyang, et al.
Publicado: (2015)

Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke
por: Lin, Jing, et al.
Publicado: (2019)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

High On-Aspirin Platelet Reactivity and Clinical Outcome in Patients With Stable Coronary Artery Disease: Results From ASCET (Aspirin Nonresponsiveness and Clopidogrel Endpoint Trial)
por: Pettersen, Alf-Åge R., et al.
Publicado: (2012)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Immature platelets and antiplatelet therapy response to aspirin in Kawasaki disease
por: Pi, Lei, et al.
Publicado: (2018)

Interactions among COX-2, GPIIIa and P2Y1 variants are associated with aspirin responsiveness and adverse events in patients with ischemic stroke
por: Yi, Xingyang, et al.
Publicado: (2016)

Risk of recurrent stroke and antiplatelet choice in breakthrough stroke while on aspirin
por: Kim, Joon-Tae, et al.
Publicado: (2020)

Antiplatelet Use in Ischemic Stroke
por: Kamarova, Marharyta, et al.
Publicado: (2022)

Economic Evaluation of Ticagrelor Plus Aspirin Versus Aspirin Alone for Acute Ischemic Stroke and Transient Ischemic Attack
por: Chen, Jigang, et al.
Publicado: (2022)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Aspirin and antiplatelet treatments in cancer
por: Tao, Derrick L., et al.
Publicado: (2021)

The secondary prevention of stroke according to cytochrome P450 2C19 genotype in patients with acute large-artery atherosclerosis stroke
por: Yi, Xingyang, et al.
Publicado: (2018)

Ischemic Benefit and Hemorrhage Risk of Ticagrelor-Aspirin Versus Aspirin in Patients With Acute Ischemic Stroke or Transient Ischemic Attack
por: Johnston, S. Claiborne, et al.
Publicado: (2021)

Personalized antiplatelet therapy guided by clopidogrel pharmacogenomics in acute ischemic stroke and transient ischemic attack: A prospective, randomized controlled trial
por: Zhang, Xiaoguang, et al.
Publicado: (2023)

Aspirin Resistance in the Acute Stages of Acute Ischemic Stroke Is Associated with the Development of New Ischemic Lesions
por: Kim, Joon-Tae, et al.
Publicado: (2015)

Platelet Function Testing-Guided Antiplatelet Therapy
por: Lenk, Ekaterina, et al.
Publicado: (2014)

Biomarkers for Antiplatelet Therapies in Acute Ischemic Stroke: A Clinical Review
por: Alhazzani, Adel, et al.
Publicado: (2021)

Analysis of Prescriptions for Dual Antiplatelet Therapy After Acute Ischemic Stroke
por: Xian, Ying, et al.
Publicado: (2022)

Comparative evaluation of antiplatelet effect of lycopene with aspirin and the effect of their combination on platelet aggregation: An in vitro study
por: Sawardekar, Swapna B., et al.
Publicado: (2016)

Genetic Association Study and Machine Learning to Investigate Differences in Platelet Reactivity in Patients with Acute Ischemic Stroke Treated with Aspirin
por: Ikonnikova, Anna, et al.
Publicado: (2022)

Thromboelastography predicts dual antiplatelet therapy-related hemorrhage in patients with acute ischemic stroke
por: He, Dan, et al.
Publicado: (2022)

Multiple Antiplatelet Therapy in Ischemic Stroke Already on Antiplatelet Agents Based on the Linked Big Data for Stroke
por: Kim, Tae Jung, et al.
Publicado: (2023)

Response to clopidogrel is associated with early neurological deterioration after acute ischemic stroke
por: Yi, Xingyang, et al.
Publicado: (2018)

Association of Cytochrome P450 Genetic Variants with Clopidogrel Resistance and Outcomes in Acute Ischemic Stroke
por: Yi, Xingyang, et al.
Publicado: (2016)

Platelet‐activating factor antagonist‐based intensive antiplatelet strategy in acute ischemic stroke: A propensity score matched with network pharmacology analysis
por: Han, Xiaoyan, et al.
Publicado: (2023)

Analysis of antiplatelet therapy adherence in patients with ischemic cerebral stroke
por: Zhong, Jie, et al.
Publicado: (2023)

Dual vs. mono antiplatelet therapy for acute ischemic stroke or transient ischemic attack with evidence of large artery atherosclerosis
por: Lin, Chun-Jen, et al.
Publicado: (2022)

The TXA2R rs1131882, P2Y1 rs1371097 and GPIIIa rs2317676 three-loci interactions may increase the risk of carotid stenosis in patients with ischemic stroke
por: Yi, Xingyang, et al.
Publicado: (2019)

Dissolvable polymeric microneedles loaded with aspirin for antiplatelet aggregation
por: Wang, Baorui, et al.
Publicado: (2023)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Antiplatelet Usage Impacts Clot Density in Acute Anterior Circulation Ischemic Stroke
por: Pikija, Slaven, et al.
Publicado: (2016)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Sex Differences in Outcomes of Intravenous Thrombolysis in Acute Ischemic Stroke Patients with Preadmission Use of Antiplatelets
por: Noseda, Roberta, et al.
Publicado: (2023)

Beyond antiplatelets: The role of glycoprotein VI in ischemic stroke
por: Induruwa, Isuru, et al.
Publicado: (2016)

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial
por: Zhou, Mengyuan, et al.
Publicado: (2020)

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
por: Schmaier, Alec A., et al.
Publicado: (2018)

High-on-Aspirin Platelet Reactivity Differs Between Recurrent Ischemic Stroke Associated With Extracranial and Intracranial Atherosclerosis
por: Noh, Kyung Chul, et al.
Publicado: (2022)

Epoxyeicosatrienoic Acids are Mediated by EPHX2 Variants and may be a Predictor of Early Neurological Deterioration in Acute Minor Ischemic Stroke
por: Yi, Xingyang, et al.
Publicado: (2017)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6dg2kvp70la34po8kgl022vt81